Skip to content
POM-V Prescription Required Companion Animal

Canixin Pi/L Lyophilisate and Suspension for Suspension for Injection for Dogs

Active ingredients: Canine parainfluenza virus, Leptospira canicola, Leptospira icterohaemorrhagiae

Form

Injection

Species

Dogs

Manufacturer

Virbac

VMD MA No.

05653/5084

What it's used for

For active immunisation of dogs from 8 weeks of age to: - reduce respiratory clinical signs and viral excretion caused by canine parainfluenza virus; - pre...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Canine parainfluenza virus +...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Canixin Pi/L Lyophilisate and Suspension for Suspension for Injection for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For active immunisation of dogs from 8 weeks of age to:
- reduce respiratory clinical signs and viral excretion caused by canine
parainfluenza virus;
- prevent mortality and reduce infection, clinical signs, kidney colonisation, renal
lesions and urine shedding of Leptospira Canicola;
- reduce infection, clinical signs, kidney colonisation and urine shedding of
Leptospira Icterohaemorrhagiae;
Onset of immunity:
The onset of immunity has been demonstrated from 4 weeks after the primary
vaccination for CPiV, 5 weeks for Leptospira Canicola and 2 weeks for Leptospira
Icterohaemorrhagiae
Duration of immunity:
The duration of immunity lasts for one year after the primary vaccination for all
components.
In the one-year duration of immunity studies there was no significant difference
between vaccinated and control dogs in viral excretion for CPiV, in reduction of
kidney colonisation for Canicola and Icterohaemorrhagiae, nor
in renal lesions and urine shedding for Leptospira Canicola.
After reconstitution of the lyophilisate with the solvent, shake gently and
administer immediately one dose of 1 ml subcutaneously according to the
following vaccination schedule:
Primary vaccination course:
- first injection from 8 weeks of age,
- second injection 3 or 4 weeks later.
Annual re-vaccination:
One booster injection of a single dose should be given 1 year after the second
injection and annually thereafter.
When active immunisation against rabies is also required, and if Virbac’s rabies
vaccine is available, 1 dose of the product can be mixed with 1 dose of Virbac’s
rabies vaccine and 2 ml of mixed vaccines can be administered immediately
subcutaneously. Refer to the Virbac’s rabies vaccine product information regarding
vaccination scheme against rabies.
The appearance of the reconstituted product is slightly yellowish beige.
None.
reaction resolves spontaneously within 1 to 2 weeks.
Some transient post-vaccinal lethargic states were commonly observed in clinical
studies.
Transient hyperthermia or digestive disturbances such as anorexia, diarrhoea or
vomiting were rarely observed from spontaneous reports.
Hypersensitivity reactions (e.g. anaphylaxis, skin manifestations such as
oedema/swelling, erythema, pruritus) have been reported in very rare cases from
spontaneous reports. In case of such an allergic or anaphylactic reaction, appropriate
symptomatic treatment should be administered.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse
reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated
reports).
Vaccinate healthy animals only.

Special precautions for use in animals:
None.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Safety and efficacy data are available which demonstrate that this vaccine can be
mixed and administered with Virbac’s rabies vaccine, if available.
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be decided on a case-by-
case basis.
Store and transport refrigerated (2 °C – 8 °C).
Protect from light.
Do not freeze.
Not applicable.
5. PROPERTIES
ATCvet code QI07AI08.
Pharmacotherapeutic group: Immunologicals for Canidae, live viral and inactivated
bacterial vaccines for dogs.
To stimulate active immunity against canine parainfluenza virus and
interrogans serogroup Canicola and Leptospira interrogans serogroup
Icterohaemorrhagiae in dogs.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.